NCT02394379View on ClinicalTrials.gov

Post Approval Study to Evaluate the Trulign™ Toric Posterior Chamber IOL

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

March 19, 2015

Primary Completion Date

August 5, 2019

Study Completion Date

August 5, 2019

Conditions
Cataract
Interventions
DEVICE

Trulign™ Toric IOL

Trulign™ Toric Posterior Chamber IOL is a modified plate haptic lens

Trial Locations (1)

14609

Bausch & Lomb Incorporated, Rochester

All Listed Sponsors
collaborator

Bausch Health Americas, Inc.

INDUSTRY

lead

Bausch & Lomb Incorporated

INDUSTRY

NCT02394379 - Post Approval Study to Evaluate the Trulign™ Toric Posterior Chamber IOL | Biotech Hunter | Biotech Hunter